期刊文献+

脓毒症的肝素治疗 被引量:2

原文传递
导出
摘要 1992年,脓毒症被美国胸科医生协会与危重病医学会定义为“感染+全身炎症反应综合征(SIRS)”,其往往由休克、感染、创伤等所致,是多脏器功能障碍综合征(MODS)的重要诱发因素”。脓毒症时炎症反应与体内促凝活性及内皮细胞活化紧密相关,由于炎症细胞因子的瀑布样释放,激活了凝血系统,不同程度的抑制纤溶系统及抗凝系统;而凝血激活、血栓形成又能通过多种途径激活炎症反应。
作者 赵聪 马晓春
出处 《中华内科杂志》 CAS CSCD 北大核心 2009年第2期165-167,共3页 Chinese Journal of Internal Medicine
  • 相关文献

参考文献28

  • 1Bauer I, Bauer M, Raddatz A, et al. Influence of gender on stimulated eytokine response in patients with severe sepsis. Anaesthesist, 2006,55 : 515 -527.
  • 2Kinasewitz GT, Yan SB, Basson B, et al. Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism. Crit Care, 2004, 8: R82-90.
  • 3Bauer PR. Microvascular responses to sepsis: clinical significance. Pathophysiology,2002,8 : 141-148.
  • 4Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med ,2001,344:699-709.
  • 5Abraham E, Laterre PF, Garg R, et al. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med ,2005,353 : 1332-1341.
  • 6Warren BL, Eid A, Singer P, et al. Caring for the critically ill patient. High-dose antithrombin Ⅲ in severe sepsis: a randomized controlled trial. JAMA ,2001,286 : 1869-1878.
  • 7Wiedermann C J, Hoffmann JN, Juers M, et al. High-dose antithrombin Ⅲ in the treatment of severe sepsis in patients with a high risk of death: efficacy and safety. Crit Care Med,2006,34: 285 -292.
  • 8Abraham E, Reiahart K, Opal S, et al. Efficacy and safety of tifaeogin (recombinant tissue factor pathway inhibitor) in severe sepsis : a randomized controlled trial. JAMA ,2003,290:238-247.
  • 9Coughlin SR. Thrombin signalling and protease-activated receptors. Nature ,2000,407 : 258 -264.
  • 10Derhaschnig U, Pernerstorfer T, Knechtelsdorfer M, et al. Evaluation of antiinflammatory and antiadhesive effects of heparins in human endotoxemia. Grit Care Med,2003,31:1108-1112.

同被引文献12

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部